Telomerase directly regulates NF-κB-dependent transcription
暂无分享,去创建一个
E. Liu | W. Sung | Guoliang Li | Zhizhuo Zhang | S. Leow | Ting-dong Yan | Shang Li | Arkasubhra Ghosh | Jianbiao Zhou | W. Chng | V. Tergaonkar | M. Wong | Ekta Khattar | Gaye Saginc | E. Shin
[1] D. Kouretas,et al. Connection between Telomerase Activity in PBMC and Markers of Inflammation and Endothelial Dysfunction in Patients with Metabolic Syndrome , 2012, PloS one.
[2] N. Perkins,et al. The diverse and complex roles of NF-κB subunits in cancer , 2012, Nature Reviews Cancer.
[3] V. D’Agati,et al. Reversible cell cycle entry in adult kidney podocytes through regulated control of telomerase and Wnt signaling , 2011, Nature Medicine.
[4] Howard Y. Chang,et al. Genomic maps of long noncoding RNA occupancy reveal principles of RNA-chromatin interactions. , 2011, Molecular cell.
[5] James M. Roberts,et al. Separation of telomerase functions by reverse genetics , 2011, Proceedings of the National Academy of Sciences.
[6] Michael Karin,et al. Inflammation meets cancer, with NF-κB as the matchmaker , 2011, Nature Immunology.
[7] S. Ghosh,et al. Crosstalk in NF-κB signaling pathways , 2011, Nature Immunology.
[8] Wing-Kin Sung,et al. CENTDIST: discovery of co-associated factors by motif distribution , 2011, Nucleic Acids Res..
[9] I. Bergin,et al. Ulcerative Typhlocolitis Associated With Helicobacter mastomyrinus in Telomerase-Deficient Mice , 2011, Veterinary pathology.
[10] T. Suda,et al. Telomerase reverse transcriptase protects ATM-deficient hematopoietic stem cells from ROS-induced apoptosis through a telomere-independent mechanism. , 2011, Blood.
[11] E. Gilson,et al. The human TTAGGG repeat factors 1 and 2 bind to a subset of interstitial telomeric sequences and satellite repeats , 2011, Cell Research.
[12] D. Hanahan,et al. Hallmarks of Cancer: The Next Generation , 2011, Cell.
[13] M. Blasco,et al. Telomeric and extra-telomeric roles for telomerase and the telomere-binding proteins , 2011, Nature Reviews Cancer.
[14] Joseph M. Connors,et al. Oncogenically active MYD88 mutations in human lymphoma , 2011, Nature.
[15] D. Bruemmer,et al. Telomerase Activation in Atherosclerosis and Induction of Telomerase Reverse Transcriptase Expression by Inflammatory Stimuli in Macrophages , 2011, Arteriosclerosis, thrombosis, and vascular biology.
[16] Robin L. Jones,et al. Nuclear NF-κB/p65 expression and response to neoadjuvant chemotherapy in breast cancer , 2010, Journal of Clinical Pathology.
[17] C. Harley,et al. The telomerase inhibitor imetelstat depletes cancer stem cells in breast and pancreatic cancer cell lines. , 2010, Cancer research.
[18] Mary Goldman,et al. The UCSC Genome Browser database: update 2011 , 2010, Nucleic Acids Res..
[19] Zhijian J. Chen,et al. ATM- and NEMO-dependent ELKS ubiquitination coordinates TAK1-mediated IKK activation in response to genotoxic stress. , 2010, Molecular cell.
[20] Luke A. Gilbert,et al. DNA Damage-Mediated Induction of a Chemoresistant Niche , 2010, Cell.
[21] D. Gordon,et al. The Emerging Role of Telomerase Reverse Transcriptase in Mitochondrial DNA Metabolism , 2010, Journal of nucleic acids.
[22] Sumit K. Chanda,et al. Telomere-independent Rap1 is an IKK adaptor and regulates NF-κB-dependent gene expression , 2010, Nature Cell Biology.
[23] Feng Lin,et al. A signal-noise model for significance analysis of ChIP-seq with negative control , 2010, Bioinform..
[24] Cory Y. McLean,et al. GREAT improves functional interpretation of cis-regulatory regions , 2010, Nature Biotechnology.
[25] Sui Huang. Faculty Opinions recommendation of An RNA-dependent RNA polymerase formed by TERT and the RMRP RNA. , 2009 .
[26] Ben S. Wittner,et al. Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1 , 2009, Nature.
[27] Timothy D. Veenstra,et al. Telomerase modulates Wnt signalling by association with target gene chromatin , 2009, Nature.
[28] S. Shreeram,et al. WIP1 phosphatase is a negative regulator of NF-κB signalling , 2009, Nature Cell Biology.
[29] L. Coussens,et al. Inflaming gastrointestinal oncogenic programming. , 2008, Cancer cell.
[30] P. Allavena,et al. Cancer-related inflammation , 2008, Nature.
[31] C. Libert,et al. Tumor necrosis factor alpha mediates the lethal hepatotoxic effects of poly(I:C) in D-galactosamine-sensitized mice. , 2008, Cytokine.
[32] C. Harley,et al. Telomerase and cancer therapeutics , 2008, Nature Reviews Cancer.
[33] S. Ghosh,et al. Shared Principles in NF-κB Signaling , 2008, Cell.
[34] R. Verdun,et al. Replication and protection of telomeres , 2007, Nature.
[35] A. Multani,et al. Telomere dysfunction suppresses spontaneous tumorigenesis in vivo by initiating p53‐dependent cellular senescence , 2007, EMBO reports.
[36] Terrence S. Furey,et al. The UCSC Genome Browser Database: update 2006 , 2005, Nucleic Acids Res..
[37] I. Verma,et al. Distinct roles of IκB proteins in regulating constitutive NF-κB activity , 2005, Nature Cell Biology.
[38] Ruth I. Tennen,et al. Conditional telomerase induction causes proliferation of hair follicle stem cells , 2005, Nature.
[39] E. Blackburn,et al. Cellular and Gene Expression Responses Involved in the Rapid Growth Inhibition of Human Cancer Cells by RNA Interference-mediated Depletion of Telomerase RNA* , 2005, Journal of Biological Chemistry.
[40] W. Hahn,et al. The telomerase reverse transcriptase regulates chromatin state and DNA damage responses. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[41] J. Shay,et al. Senescence and immortalization: role of telomeres and telomerase. , 2005, Carcinogenesis.
[42] Y. Ben-Neriah,et al. NF-κB functions as a tumour promoter in inflammation-associated cancer , 2004, Nature.
[43] James B. Mitchell,et al. Nuclear Factor-κB is an Important Modulator of the Altered Gene Expression Profile and Malignant Phenotype in Squamous Cell Carcinoma , 2004, Cancer Research.
[44] E. Blackburn,et al. Rapid Inhibition of Cancer Cell Growth Induced by Lentiviral Delivery and Expression of Mutant-Template Telomerase RNA and Anti-telomerase Short-Interfering RNA , 2004, Cancer Research.
[45] S. Saccani,et al. Degradation of Promoter-bound p65/RelA Is Essential for the Prompt Termination of the Nuclear Factor κB Response , 2004, The Journal of experimental medicine.
[46] K. Isobe,et al. Dramatic increase of telomerase activity during dendritic cell differentiation and maturation , 2003, Journal of leukocyte biology.
[47] James M. Roberts,et al. Telomerase modulates expression of growth-controlling genes and enhances cell proliferation , 2003, Nature Cell Biology.
[48] R. DePinho,et al. Telomerase extracurricular activities , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[49] Robert A. Weinberg,et al. Telomerase contributes to tumorigenesis by a telomere length-independent mechanism , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[50] T. Tsuruo,et al. Telomere shortening and growth inhibition of human cancer cells by novel synthetic telomerase inhibitors MST-312, MST-295, and MST-1991. , 2002, Molecular cancer therapeutics.
[51] Tom H. Pringle,et al. The human genome browser at UCSC. , 2002, Genome research.
[52] R. DePinho,et al. Constitutive telomerase expression promotes mammary carcinomas in aging mice , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[53] M. Blasco,et al. Increased epidermal tumors and increased skin wound healing in transgenic mice overexpressing the catalytic subunit of telomerase, mTERT, in basal keratinocytes , 2001, The EMBO journal.
[54] G. Cai,et al. Expression of telomerase inhibits hydroxyl radical‐induced apoptosis in normal telomerase negative human lung fibroblasts , 2001, FEBS letters.
[55] P. Finnon,et al. Short Telomeres Result in Organismal Hypersensitivity to Ionizing Radiation in Mammals , 2000, The Journal of experimental medicine.
[56] L. Yin,et al. NF-κB Regulates Transcription of the Mouse Telomerase Catalytic Subunit* , 2000, The Journal of Biological Chemistry.
[57] K. Collins,et al. A telomerase component is defective in the human disease dyskeratosis congenita , 1999, Nature.
[58] T. Gilmore,et al. Control of apoptosis by Rel/NF-κB transcription factors , 1999, Oncogene.
[59] G. Haegeman,et al. The Nuclear Factor-κB Engages CBP/p300 and Histone Acetyltransferase Activity for Transcriptional Activation of the Interleukin-6 Gene Promoter* , 1999, The Journal of Biological Chemistry.
[60] R. Hay,et al. Mutations in the IkBa gene in Hodgkin's disease suggest a tumour suppressor role for IκBα , 1999, Oncogene.
[61] W. Hahn,et al. Dissociation among in vitro telomerase activity, telomere maintenance, and cellular immortalization. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[62] R. Reddel. Telomerase and cancer. , 1997, Japanese journal of cancer research : Gann.
[63] A. Takashima,et al. Mechanisms regulating telomerase activity in murine T cells. , 1997, Journal of immunology.
[64] Seamus J. Martin,et al. Suppression of TNF-α-Induced Apoptosis by NF-κB , 1996, Science.
[65] R. Effros,et al. Mechanism of telomerase induction during T cell activation. , 1996, Experimental cell research.
[66] D. Hanahan,et al. Differential regulation of telomerase activity and telomerase RNA during multi-stage tumorigenesis , 1996, Nature Genetics.
[67] T. Mak,et al. Mice deficient for the 55 kd tumor necrosis factor receptor are resistant to endotoxic shock, yet succumb to L. monocytogenes infection , 1993, Cell.
[68] L. Hayflick. THE LIMITED IN VITRO LIFETIME OF HUMAN DIPLOID CELL STRAINS. , 1965, Experimental cell research.
[69] M. Hande,et al. hTERT overexpression alleviates intracellular ROS production, improves mitochondrial function, and inhibits ROS-mediated apoptosis in cancer cells. , 2011, Cancer research.
[70] A. Baldwin,et al. Requirement of the NF- κ B Subunit p65/RelA for K-Ras – Induced Lung Tumorigenesis , 2010 .
[71] N. Perkins,et al. Integrating cell-signalling pathways with NF-κB and IKK function , 2007, Nature Reviews Molecular Cell Biology.
[72] E. Blackburn,et al. Recognition and elongation of telomeres by telomerase. , 1989, Genome.